TATVA — Tatva Chintan Pharma Chem Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹25.18bn
- IN₹24.83bn
- IN₹3.94bn
Annual cashflow statement for Tatva Chintan Pharma Chem, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | C2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 476 | 607 | 1,041 | 448 | 436 |
| Depreciation | |||||
| Non-Cash Items | 39 | 2.82 | 19.5 | 116 | 33.4 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -310 | -480 | -939 | -382 | 255 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 253 | 197 | 204 | 278 | 980 |
| Capital Expenditures | -482 | -210 | -892 | -2,031 | -1,285 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 79.9 | 3.11 | -1,076 | 1,020 | 79.8 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -402 | -207 | -1,968 | -1,011 | -1,205 |
| Financing Cash Flow Items | -35.9 | -42.7 | 2,032 | -128 | 1,841 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 99.5 | -47.1 | 2,350 | 378 | 305 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -49.2 | -56.8 | 585 | -357 | 79.4 |